Advertisement
Recommendations from the Fourth World Workshop on Oral Medicine| Volume 103, SUPPLEMENT , S57.e1-S57.e15, March 2007

Download started.

Ok

Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations

      Objectives

      The objective of this study was to identify systemic diseases associated with hyposalivation and xerostomia and develop evidence-based management recommendations for hyposalivation/xerostomia.

      Study design

      Literature searches covered the English language medical literature from 1966 to 2005. An evidence-based review process was applied to management studies published from 2002 to 2005.

      Results

      Several systemic diseases were identified. From studies published 2002 to 2005, 15 were identified as high-quality studies and were used to support management recommendations: pilocarpine and cevimeline are recommended for treating hyposalivation and xerostomia in primary and secondary Sjögren’s syndrome (SS). IFN-α lozenges may enhance saliva flow in primary SS patients. Anti-TNF-α agents, such as infliximab or etanercept, are not recommended to treat hyposalivation in SS. Dehydroepiandrosterone is not recommended to relieve hyposalivation or xerostomia in primary SS. There was not enough evidence to support any recommendations for the use of local stimulants, lubricants, and protectants for hyposalivation/xerostomia. However, professional judgment and patient preferences may support the use of a specific product for an individual patient.

      Conclusions

      These evidence-based management recommendations should guide the clinician’s management decisions for patients with salivary dysfunction related to systemic disease. Future treatment strategies may include new formulations of existing drugs, e.g., local application of pilocarpine. Recent discoveries on gene expression and a better understanding of the etiopathogenesis of SS may open new treatment options in the future.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Millard H.D.
        • Mason D.K.
        Third World Workshop on Oral Medicine. University of Michigan, Ann Arbor (MI)1998
        • Boyce H.W.
        • Bakheet M.R.
        Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease.
        J Clin Gastroenterol. 2005; 39: 89-97
        • Dawes C.
        Physiological factors affecting salivary flow rate, oral sugar clearance and the sensation of dry mouth in man.
        J Dent Res. 1987; 66: 648-653
        • Tylenda C.A.
        • Ship J.A.
        • Fox P.C.
        • Baum B.J.
        Evaluation of submandibular salivary flow rate in different age groups.
        J Dent Res. 1988; 67: 1225-1228
        • Ghezzi E.M.
        • Wagner-Lange L.A.
        • Schork M.A.
        • Metter E.J.
        • Baum B.J.
        • Streckfus C.F.
        • et al.
        Longitudinal influence of age, menopause, hormone deplacement, and other medications on parotid flow rates in healthy women.
        J Gerontol A Biol Sci Med Sci. 2000; 55: M34-M42
        • Ghezzi E.M.
        • Ship J.A.
        Aging and secretory reserve capacity of major salivary glands.
        J Dent Res. 2003; 82: 844-848
        • Millard H.D.
        • Mason D.K.
        Second World Workshop on Oral Medicine. University of Michigan, Ann Arbor (MI)1993
        • Brennan M.T.
        • Shariff G.
        • Lockhart P.B.
        • Fox P.C.
        Treatment of xerostomia: a systematic review of therapeutic trials.
        Dent Clin N Am. 2002; 46: 847-856
      1. Methodologies and Policies from the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Available at: http://circ.ahajournals.org/manual/manual_I.shtml. Accessed May 2005.

        • Liddle J.
        • Williamson M.
        • Irwig L.
        Method for evaluating research guideline evidence. NSW Health Department, Sydney, Australia1996 (State Health publication no. (CEB) 96-204.)
        • Edgar W.
        • O’Mullane D.
        • Dawes C.
        Saliva and oral health. 3rd ed. British Dental Association, London2004
        • Gannot G.
        • Lancaster H.E.
        • Fox P.C.
        Clinical course of primary Sjogren’s syndrome: salivary, oral, and serologic aspects.
        J Rheumatol. 2000; 27: 1905-1909
        • Jonsson R.
        • Kroneld U.
        • Bäckman K.
        • Magnusson B.
        • Tarkowski A.
        Progression of sialadenitis in Sjögren’s syndrome.
        Br J Rheumatol. 1993; 32: 578-581
        • Daniels T.E.
        • Whitcher J.P.
        Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca.
        Arthritis Rheum. 1994; 37: 869-877
        • Adamson 3rd, T.C.
        • Fox R.I.
        • Frisman D.M.
        • Howell F.V.
        Immunohistologic analysis of lymphoid infiltrates in primary Sjogren’s syndrome using monoclonal antibodies.
        J Immunol. 1983; 130: 203-208
        • Jonsson R.
        • Bowman S.J.
        • Gordon T.P.
        Sjögren’s syndrome in arthritis and allied conditions.
        in: Koopman W.J. Moreland L.W. A textbook of rheumatology. 15th ed. Lippincott, Williams and Wilkins, Philadelphia2005: 1681-1705
        • Garcia-Carrasco M.
        • Ramos-Casals M.
        • Rosas J.
        • Pallares L.
        • Calvo-Alen J.
        • Cervera R.
        • et al.
        Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients.
        Medicine (Baltimore). 2002; 81: 270-280
        • Leung K.C.
        • McMillan A.S.
        • Leung W.K.
        • Wong M.C.
        • Lau C.S.
        • Mok T.M.
        Oral health condition and saliva flow in southern Chinese with Sjogren’s syndrome.
        Int Dent J. 2004; 54: 159-165
        • Márton K.
        • Boros I.
        • Fejérdy P.
        • Madléna M.
        Evaluation of unstimulated flow rates of whole and palatal saliva in healthy patients wearing complete dentures and in patients with Sjögren’s syndrome.
        J Prosthet Dent. 2004; 91: 577-581
        • Kassan S.S.
        • Thomas T.L.
        • Moutsopoulos H.M.
        • Hoover R.
        • Kimberly R.P.
        • Budman D.R.
        • et al.
        Increased risk of lymphoma in sicca syndrome.
        Ann Intern Med. 1978; 89: 888-892
        • Zintzaras E.
        • Voulgarelis M.
        • Moutsopoulos H.M.
        The risk of lymphoma development in autoimmune diseases: a meta-analysis.
        Arch Intern Med. 2005; 165: 2337-2344
        • Vitali C.
        • Bombardieri S.
        • Jonsson R.
        • Moutsopoulos H.M.
        • Alexander E.L.
        • Carsons S.E.
        • et al.
        and the European Study Group on Classification Criteria for Sjogren’s Syndrome.
        Ann Rheum Dis. 2002; 61: 554-558
        • Fujibayashi T.
        • Sugai S.
        • Miyasaka N.
        • Hayashi Y.
        • Tsubota K.
        Revised Japanese criteria for Sjögren’s syndrome (1999): availability and validity.
        Mod Rheumatol. 2004; 14: 425-434
        • Vitali C.
        • Bombardieri S.
        • Moutsopoulos H.M.
        • Coll J.
        • Gerli R.
        • Hatron P.Y.
        • et al.
        • The European Study Group on Diagnostic Criteria for Sjogren’s Syndrome
        Assessment of the European classification criteria for Sjogren’s syndrome in a series of clinically defined cases: results of a prospective multicentre study.
        Ann Rheum Dis. 1996; 55: 116-121
        • Garberg H.
        • Jonsson R.
        • Brokstad K.A.
        The serological pattern of autoantibodies to the Ro52, Ro60, and La48 autoantigens in primary Sjogren’s syndrome patients and healthy controls.
        Scand J Rheumatol. 2005; 34: 49-55
        • Jonsson M.V.
        • Szodoray P.
        • Jellestad S.
        • Jonsson R.
        • Skarstein K.
        Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren’s syndrome.
        J Clin Immunol. 2005; 25: 189-201
        • Szodoray P.
        • Alex P.
        • Jonsson M.V.
        • Knowlton N.
        • Dozmorov I.
        • Nakken B.
        • et al.
        Distinct profiles of Sjogren’s syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF.
        Clin Immunol. 2005; 117: 168-176
        • Hjelmervik T.O.
        • Petersen K.
        • Jonassen I.
        • Jonsson R.
        • Bolstad A.I.
        Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren’s syndrome patients from healthy control subjects.
        Arthritis Rheum. 2005; 52: 1534-1544
        • Moen K.
        • Bertelsen L.T.
        • Hellem S.
        • Jonsson R.
        • Brun J.G.
        Salivary gland and temporomandibular joint involvement in rheumatoid arthritis: relation to disease activity.
        Oral Dis. 2005; 11: 27-34
        • Jensen J.L.
        • Uhlig T.
        • Kvien T.K.
        • Axell T.
        Characteristics of rheumatoid arthritis patients with self-reported sicca symptoms: evaluation of medical, salivary and oral parameters.
        Oral Dis. 1997; 3: 254-261
        • Nederfors T.
        • Holmstrom G.
        • Paulsson G.
        • Sahlberg D.
        The relation between xerostomia and hyposalivation in subjects with rheumatoid arthritis or fibromyalgia.
        Swed Dent J. 2002; 26: 1-7
        • Nagler R.M.
        • Salameh F.
        • Reznick A.Z.
        • Livshits V.
        • Nahir A.M.
        Salivary gland involvement in rheumatoid arthritis and its relationship to induced oxidative stress.
        Rheumatology (Oxford). 2003; 42: 1234-1241
        • Helenius L.M.
        • Meurman J.H.
        • Helenius I.
        • Kari K.
        • Hietanen J.
        • Suuronen R.
        • et al.
        Oral and salivary parameters in patients with rheumatic diseases.
        Acta Odontol Scand. 2005; 63: 284-293
        • Brun J.G.
        • Madland T.M.
        • Jonsson R.
        A prospective study of sicca symptoms in patients with rheumatoid arthritis.
        Arthritis Rheum. 2003; 49: 187-192
        • Walton A.G.
        • Welbury R.R.
        • Foster H.E.
        • Wright W.G.
        • Thomason J.M.
        Sialochemistry in juvenile idiopathic arthritis.
        Oral Dis. 2002; 8: 287-290
        • Rhodus N.L.
        • Johnson D.K.
        The prevalence of oral manifestations of systemic lupus erythematosus.
        Quintessence Int. 1990; 21: 461-465
        • Jensen J.L.
        • Bergen H.O.
        • Gilboe I.-M.
        • Husby G.
        • Axell T.
        Oral and occular sicca symptoms and findings are prevalent in systemic lupus erythematosus.
        J Oral Pathol Med. 1999; 28: 317-322
        • Grennan D.M.
        • Ferguson M.
        • Ghobarey A.E.
        • Williamson J.
        • Dick W.C.
        • Buchanan W.W.
        Sjögren’s syndrome in SLE.
        NZ Med J. 1977; 86: 374-376
        • Ben-Aryeh H.
        • Gordon N.
        • Szargel R.
        • Toubi E.
        • Laufer D.
        Whole saliva in systemic lupus erythematosus patients.
        Oral Surg Oral Med Oral Pathol. 1993; 75: 696-699
        • Jonsson R.
        • Bratthall D.
        • Nyberg G.
        Histological and sialochemical findings indicating sicca syndrome in patients with systemic lupus erythematosus.
        Oral Surg Oral Med Oral Pathol. 1982; 54: 635-639
        • Janin A.
        • Gosselin B.
        • Gosset D.
        • Hatron P.Y.
        • Sauvezie B.
        Histological criteria of Sjogren’s syndrome in scleroderma.
        Clin Exp Rheumatol. 1989; 7: 167-169
        • Ikuno N.
        • Mackay I.R.
        • Jois J.
        • Omagari K.
        • Rowley M.J.
        Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis.
        J Gastroenterol Hepatol. 2001; 16: 13904
        • Reynoso-Paz S.
        • Leung P.S.
        • Van De Water J.
        • Tanaka A.
        • Munoz S.
        • Bass N.
        • et al.
        Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.
        Hepatology. 2000; 31: 24-29
        • Tsuneyama K.
        • Van De Water J.
        • Yamazaki K.
        • Suzuki K.
        • Sato S.
        • Takeda Y.
        • et al.
        Primary biliary cirrhosis and epithelitis: evidence of abnormal salivary gland immunohistochemistry.
        Autoimmunity. 1997; 26: 23-31
        • Mang F.W.
        • Michieletti P.
        • O’Rourke K.
        • Cauch-Dudek K.
        • Diamant N.
        • Bookman A.
        • et al.
        Primary biliary cirrhosis, sicca complex, and dysphagia.
        Dysphagia. 1997; 12: 167-170
        • Surattanont F.
        • Mandel L.
        • Wolinsky B.
        Bilateral parotid swelling caused by sarcoidosis.
        J Am Dent Assoc. 2002; 133: 738-741
        • Drosos A.
        • Voulgari P.
        • Psychos D.
        • Tsifetaki N.
        • Bai M.
        Sicca syndrome in patients with sarcoidosis.
        Rehumatol Int. 1999; 18: 177-180
        • Sack K.
        • Whitcher J.
        • Carteron N.
        • Greenspan J.
        • Daniels T.E.
        Sarcoidosis mimicking Sjögren’s syndrome: histopathological observations.
        J Clin Rheumatol. 1998; 4: 13-16
        • Sreebny L.M.
        • Yu A.
        • Green A.
        • Valdini A.
        Xerostomia in diabetes mellitus.
        Diabetes Care. 1992; 15: 900-904
        • Moore P.A.
        • Guggenheimer J.
        • Etzel K.R.
        • Weyant R.J.
        • Orchard T.
        Type 1 diabetes mellitus, xerostomia and salivary flow rates.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 92: 281-291
        • López M.E.
        • Colloca M.E.
        • Páez R.G.
        • Schallmach J.N.
        • Koss M.A.
        • Chervonagura A.
        Salivary characteristics of diabetic children.
        Braz Dent J. 2003; 14: 26-31
        • Mata A.D.
        • Marques D.
        • Rocha S.
        • Francisco H.
        • Santos C.
        • Mesquita M.F.
        • et al.
        Effects of diabetes mellitus on salivary secretion and its composition in the human.
        Mol Cell Biochem. 2004; 261: 137-142
        • Dodds M.W.J.
        • Dodds A.P.
        Effects of glycemic control on saliva flow rates and protein composition in non-insulin-dependant diabetes mellitus.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997; 83: 465-470
        • Dodds M.W.J.
        • Yeh C.-K.
        • Johnson D.A.
        Salivary alterations in type 2 (non-insulin-dependant) diabetes mellitus and hypertension.
        Community Dent Epidemiol. 2000; 28: 373-381
        • Chávez E.M.
        • Borrell L.N.
        • Taylor G.W.
        • Ship J.A.
        A longidudinal analysis of salivary flow in control subjects and older adults with type 2 diabetes.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 91: 166-173
        • Anderson L.C.
        • Garrett J.R.
        Neural regulation of submandibular gland blood flow in the streptozotocin-diabetic rat: evidence for impaired endothelium-dependant vasodilatation.
        Arch Oral Biol. 2004; 49: 183-191
        • Schiødt M.
        • Atkinson J.C.
        • Greenspan D.
        • Fox P.C.
        • Dodd C.L.
        • Daniels T.E.
        • et al.
        Sialochemistry in human immunodeficiency virus associated salivary gland disease.
        J Rheumatol. 1992; 19: 26-29
        • Schiødt M.
        • Greenspan D.
        • Daniels T.E.
        • Nelson J.
        • Leggott P.J.
        • Wara D.W.
        • et al.
        Parotid gland enlargement and xerostomia associated with labial sialadenitis in HIV-infected patients.
        J Autoimmun. 1989; 2: 415-425
        • Schiødt M.
        • Dodd C.L.
        • Greenspan D.
        • Daniels T.E.
        • Chernoff D.
        • Hollander H.
        • et al.
        Natural history of HIV-associated salivary gland disease.
        Oral Surg Oral Med Oral Pathol. 1992; 74: 326-331
        • Yeh C.K.
        • Fox P.C.
        • Ship J.A.
        • Busch K.A.
        • Bermudez D.K.
        • Wilder A.M.
        • et al.
        Oral defence mechanisms are impaired early in HIV-1 infected patients.
        J Acquir Immune Defic Syndr. 1988; 1: 361-366
        • Atkinson J.C.
        • Yeh C.-K.
        • Bermudez D.
        • Fox P.C.
        • Baum B.J.
        Longitudinal evaluation of major salivary gland function in HIV-1 infected patients.
        J Oral Pathol Med. 1989; 18: 469-470
        • Navazesh M.
        • Mulligan R.
        • Komaroff E.
        • Redford M.
        • Greenspan D.
        • Phelan J.
        The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women.
        J Dent Res. 2000; 79: 1502-1507
        • Mandel I.D.
        • Barr C.E.
        • Turgeon L.
        Longitudinal study of parotid saliva in HIV-1 infection.
        J Oral Pathol Med. 1992; 21: 209-213
        • Navazesh M.
        • Mulligan R.
        • Barrón Y.
        • Redford M.
        • Greenspan D.
        • Alves M.
        • et al.
        A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women’s Interagency HIV study participants.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003; 95: 693-698
        • Lin A.L.
        • Johnson D.A.
        • Stephan K.T.
        • Yeh C.K.
        Alteration in salivary function in early HIV infection.
        J Dent Res. 2003; 82: 719-724
        • Greenberg M.S.
        • Glick M.
        • Nghiem L.
        • Stewrat J.C.
        • Hodinka R.
        • Dubin G.
        Relationship of cytomegalovirus to salivary gland dysfunction in HIV-infected patients.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997; 83: 334-339
        • Almasio P.
        • Provenzano G.
        • Scimemi M.
        • Cascio G.
        • Craxi A.
        • Pagliaro L.
        Hepatitis C virus and Sjogren’s syndrome.
        Lancet. 1992; 339: 989-990
        • Haddad J.
        • Deny P.
        • Munz-Gotheil C.
        • Ambrosini J.C.
        • Trinchet J.C.
        • Pateron D.
        • et al.
        Lymphocytic sialiadenitis of Sjögren’s syndrome associated with chronic hepatitis C virus liver disease.
        Lancet. 1992; 339: 321-323
        • Pawlotsky J.M.
        • Ben Yahia M.
        • Andre C.
        • Voisin M.C.
        • Intrator L.
        • Roudot-Thoraval F.
        • et al.
        Immunological disorders in C virus chronic active hepatitis: a prospective case-control study.
        Hepatology. 1994; 19: 841-848
        • Pirisi M.
        • Scott C.
        • Fabris C.
        • Ferraccioli G.
        • Soardo G.
        • Ricci R.
        • et al.
        Mild sialoadenitis: a common finding in patients with hepatitis C virus infection.
        Scand J Gastroenterol. 1994; 29: 940-942
        • Taliani G.
        • Celestino D.
        • Badolato M.C.
        • Pennica A.
        • Bozza A.
        • Poliandri G.
        • et al.
        Hepatitis C virus infection of salivary gland epithelial cells.
        J Hepatol. 1997; 26: 1200-1206
        • Cacoub P.
        • Poynard T.
        • Ghillani P.
        • Charlotte F.
        • Olivi M.
        • Piette J.C.
        • et al.
        • MULTIVIRC Group
        Extrahepatic manifestations of chronic hepatitis C.
        Multidepartment Virus C. Arthritis Rheum. 1999; 42: 2204-2212
        • Cacoub P.
        • Renou C.
        • Rosenthal E.
        • Cohen P.
        • Loury I.
        • Loustaud-Ratti V.
        • et al.
        Extrahepatic manifestations associated with hepatitis C virus infection.
        The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Baltimore). 2000; 79: 47-56
        • Verbaan H.
        • Carlson J.
        • Eriksson S.
        • Larsson A.
        • Liedholm R.
        • Manthorpe R.
        • et al.
        Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjogren’s syndrome and hepatitis C in Swedish patients.
        J Intern Med. 1999; 245: 127-132
        • Coates E.A.
        • Brennan D.
        • Logan R.M.
        • Goss A.N.
        • Scopacasa B.
        • Spencer A.J.
        • et al.
        Hepatitis C infection and associated oral health problems.
        Aust Dent J. 2000; 45: 102-114
        • Henderson L.
        • Muir M.
        • Mills P.R.
        • Spence E.
        • Fox R.
        • McCruden E.A.
        • et al.
        Oral health of patients with hepatitis C virus infection: a pilot study.
        Oral Dis. 2001; 7: 271-274
        • Loustaud-Ratti V.
        • Riche A.
        • Liozon E.
        • Labrousse F.
        • Sorla P.
        • Rogez S.
        • et al.
        Prevalence and characteristics of Sjögren’s or sicca syndrome in chronic hepatitis C virus infection: A prospective study.
        J Reumatol. 2001; 28: 2245-2251
        • Ferreiro M.C.
        • Prieto M.H.
        • Rodriguez S.B.
        • Vázguez L.
        • Iglesias A.C.
        • Dios P.D.
        Whole stimulated salivary flow in patients with chronic hepatitis C virus infection.
        J Oral Pathol Med. 2002; 31: 117-120
        • Carrozzo M.
        • Gandolfo S.
        Oral diseases possibly related to hepatitis C virus.
        Crit Rev Oral Biol Med. 2003; 14: 115-127
        • Scott C.A.
        • Avellini C.
        • Desinan L.
        • Pirisi M.
        • Ferraccioli G.F.
        • Bardus P.
        • et al.
        Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjogren’s syndrome.
        Histopathology. 1997; 30: 41-48
        • Nordgarden H.
        • Jensen J.L.
        • Storhaug K.
        Oligodontia is associated with extra-oral ectodermal symptoms and low whole salivary flow rates.
        Oral Dis. 2001; 7: 226-232
        • Nordgarden H.
        • Storhaug K.
        • Lyngstadaas S.P.
        • Jensen J.L.
        Salivary gland function in persons with ectodermal dysplasia.
        Eur J Oral Sci. 2003; 111: 371-376
        • McDonald F.G.
        • Mantas J.
        • McEwen C.G.
        • Ferguson M.M.
        Salivary gland aplasia: an ectodermal disorder?.
        J Oral Pathol. 1986; 15: 115-117
      2. Singh P, Warnakulasuriya S. Aplasia of submandibular salivary glands associated with ectodermal dysplasia. J Oral Pathol Med 1004;33:634-6.

        • Brown C.C.
        The parotid puzzle: a review of the literature on human salivation and its applications to psychophysiology.
        Psychophysiology. 1970; 7: 65-85
        • Bergdahl M.
        • Bergdahl J.
        • Johansson I.
        Depressive symptoms in individuals with idiopathic subjective dry mouth.
        J Oral Pathol Med. 1997; 26: 448-450
        • Anttila S.S.
        • Knuuttila M.L.
        • Sakki T.K.
        Depressive symptoms as an underlying factor of the sensation of dry mouth.
        Psychosom Med. 1998; 60: 215-218
        • Changlai S.P.
        • Chen W.K.
        • Chung C.
        • Chiou S.M.
        Objective evidence of decreased salivary function in patients with autoimmune thyroditis (chronic thyroditis, Hashimoto’s thyroditis).
        Nucl Med Commun. 2002; 23: 1029-1033
        • Hansen B.U.
        • Ericson U.B.
        • Henricsson V.
        • Larsson A.
        • Manthorpe R.
        • Warfvinge G.
        Autoimmune thyroditis and primary Sjögren’s syndrome: clinical and laboratory evidence of the coexistence of the two diseases.
        Clin Exp Rheumatol. 1991; 9: 137-141
        • Warfvinge G.
        • Larsson A.
        • Henricsson V.
        • Ericsson U.-B.
        • Hansen B.
        • Manthorpe R.
        Salivary gland involvement in autoimmune thyrositis, with special reference to the degree of association with Sjögren’s syndrome.
        Oral Surg Oral Med Oral Pathol. 1992; 74: 288-293
        • Kamisawa T.
        • Tu Y.
        • Egawa N.
        • Sakaki N.
        • Inokuma S.
        • Kamata N.
        Salivary gland involvement in chronic pancreatitis of various etiologies.
        Am J Gastroenterol. 2003; 98: 323-326
        • Noronha M.
        • Dreiling D.A.
        • Bordalo O.
        The parotid and the pancreas.
        Am J Gastroenterol. 1978; 70: 282-285
        • Baldas V.
        • Tommasini A.
        • Santon D.
        • Not T.
        • Gerarduzzi T.
        • Clarich G.
        • et al.
        Testing for anti-human transglutaminase antibodies in saliva is not useful for diagnosis of celiac disease.
        Clin Chem. 2004; 50: 216-219
        • Hakeem V.
        • Fifield R.
        • al-Bayaty H.F.
        • Aldred M.J.
        • Walker D.M.
        • Williams J.
        • et al.
        Salivary IgA antigliadin antibody as a marker for coeliac disease.
        Arch Dis Child. 1992; 67: 724-727
        • Lenander-Lumikari M.
        • Ihalin R.
        • Lahteenoja H.
        Changes in whole saliva in patients with coeliac disease.
        Arch Oral Biol. 2000; 45: 347-354
        • Warner R.H.
        • Stevens F.M.
        • McCarthy C.F.
        Salivary SIgA and SIgA 1 in coeliac disease, inflammatory bowel disease and controls.
        Ir J Med Sci. 1999; 168: 33-35
        • Aps J.K.
        • Delanghe J.
        • Martens L.C.
        Salivary electrolyte concentrations are associated with cystic fibrosis transmembrane regulator genotypes.
        Clin Chem Lab Med. 2002; 40: 345-350
        • Davies H.
        • Bagg J.
        • Goodchild M.C.
        • McPherson M.A.
        Examination of submandibular fluid in cystic fibrosis.
        Acta Univ Carol [Med]. 1990; 36: 84-85
        • Kinirons M.J.
        Increased salivary buffering in association with a low caries experience in children suffering from cystic fibrosis.
        J Dent Res. 1983; 62: 815-817
        • Slomiany B.L.
        • Aono M.
        • Murty V.L.N.
        • Slomiany A.
        • Levine M.J.
        • Tabak L.A.
        Lipid composition of submandibular saliva from normal and cystic fibrosis individuals.
        J Dent Res. 1982; 61: 1163-1166
        • Chaushu S.
        • Becker A.
        • Chaushu G.
        • Shapira J.
        Stimulated parotid salivary flow rate in patients with Down syndrome.
        Spec Care Dentist. 2002; 22: 41-44
        • Cogulu D.
        • Sabah E.
        • Kutukculer N.
        • Ozkinay F.
        Evaluation of the relationship between caries indices and salivary secretory IgA, salivary pH, buffering capacity and flow rate in children with Down’s syndrome.
        Arch Oral Biol. 2006; 51: 23-28
        • Cutress T.W.
        Composition, flow-rate and pH of mixed and parotid salivas from trisomic 21 and other mentally retarded subjects.
        Arch Oral Biol. 1972; 17: 1081-1094
        • Limbrock G.J.
        • Fischer-Brandies H.
        • Avalle C.
        Castillo-Morales’ orofacial therapy: treatment of 67 children with Down syndrome.
        Dev Med Child Neurol. 1991; 33: 296-303
        • Yarat A.
        • Akyüz S.
        • Koc L.
        • Erdem H.
        • Emekli N.
        Salivary sialic acid, protein, salivary flow rate, pH, buffering capacity and caries indices in subjects with Down’s syndrome.
        J Dent. 1999; 27: 115-118
        • Johansson I.
        • Ryberg M.
        • Steen L.
        • Wigren L.
        Salivary hypofunction in patients with familial amyloidotic polyneuropathy.
        Oral Surg Oral Med Oral Pathol. 1992; 74: 742-748
        • Engvall M.
        • Birkhed D.
        Oral sugar clearance and other caries-related factors in patients with myotonic dystrophy.
        Acta Odontol Scand. 1997; 55: 111-115
        • Haneke E.
        The Papillon-Lefèvre syndrome: keratosis palmoplantaris with periodontopathy: report of a case and review of the cases in the literature.
        Human Genet. 1979; 51: 1-35
        • Lundgren T.
        • Twetman S.
        • Johansson I.
        • Crossmer C.G.
        • Birkhed D.
        Saliva composition in children and young adults with Papillon-Lefèvre syndrome.
        J Clin Periodontol. 1996; 23: 1068-1072
        • Hart P.S.
        Salivary abnormalities in Prader-Willi syndrome.
        Ann N Y Acad Sci. 1998; 842: 125-131
        • Dayan B.
        • Elstein D.
        • Zimran A.
        • Nesher G.
        Decreased salivary output in patients with Gaucher disease.
        Q J Med. 2003; 96: 53-56
        • Gertz M.A.
        • Lacy M.Q.
        • Dispenzieri A.
        • Hayman S.R.
        Amyloidosis: diagnosis and management.
        Clin Lymphoma Myeloma. 2005; 6: 208-219
        • Myssiorek D.
        • Alvi A.
        • Bhuiya T.
        Primary salivary gland amyloidosis causing sicca syndrome.
        Ann Otol Rhinol Laryngol. 1992; 101: 487-490
        • Schima W.
        • Amann G.
        • Steiner E.
        • Steurer M.
        • Vormittag W.
        • Steurer L.
        Case report: sicca syndrome due to primary amyloidosis.
        Br J Radiol. 1994; 67: 1023-1025
        • Richey T.K.
        • Bennion S.D.
        Etiologies of the sicca syndrome: primary systemic amyloidosis and others.
        Int J Dermatol. 1996; 35: 553-557
        • Vazquez M.
        • Teruel J.L.
        Sicca syndrome due to amyloidosis.
        J Oral Maxillofac Surg. 1988; 46: 1013-1014
        • Mishra O.P.
        • Agarwal K.N.
        • Agarwal R.M.
        Salivary iron status in children with iron deficiency and iron overload.
        J Trop Pediatr. 1992; 38: 64-67
        • iamopoulou-Mavridou A.
        • Mavridis A.
        • Galanakis E.
        • Vasakos S.
        • Fatourou H.
        • Lapatsanis P.
        Flow rate and chemistry of parotid saliva related to dental caries and gingivitis in patients with thalassaemia major.
        Int J Paediatr Dent. 1992; 2: 93-97
        • Vaiopoulos G.
        • Konstantopoulos K.
        • Kittas C.
        • Hatzakis A.
        • Bogdanos K.
        • Mastrovassilopoulos A.
        • et al.
        Histological and functional changes in the salivary glands an thalassemia major.
        Haematologia (Budap). 1995; 27: 33-38
        • Ship J.A.
        • Fischer D.J.
        The relationship between dehydration and parotid salivary gland function in young and older healthy adults.
        J Gerontol A Biol Sci Med Sci. 1997; 52: M310-M319
        • Riad M.
        • Barton J.R.
        • Wilson J.A.
        • Freeman C.P.L.
        • Maran A.G.D.
        Parotid salivary secretory pattern in bulimia nervosa.
        Acta Otolaryngol. 1991; 111: 392-395
        • Bots C.P.
        • Brand H.S.
        • Veerman E.C.I.
        • Korevaar J.C.
        • Valentijn-Benz M.
        • Bezemer P.D.
        • et al.
        Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on haemodialysis.
        Nephrol Dial Transplant. 2005; 20: 578-584
        • Kao C.H.
        • Hsieh J.F.
        • Tsai S.C.
        • Ho Y.J.
        • Chang H.R.
        Decreased salivary function in patients with end-stage renal disease requiring hemodialysis.
        Am J Kidney Dis. 2000; 36: 1110-1114
        • Kaya M.
        • Cermik T.F.
        • Ustun F.
        • Sen S.
        • Berkarda S.
        Salivary function in patients with chronic renal failure undergoing hemodialysis.
        Ann Nucl Med. 2002; 16: 117-120
        • Kho H.S.
        • Lee S.W.
        • Chung S.C.
        • Kim Y.K.
        Oral manifestations and salivary flow rate, pH, and buffer capacity in patients with end-stage renal disease undergoing hemodialysis.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88: 316-319
        • Dormenval V.
        • Budtz-Jorgensen E.
        • Mojon P.
        • Bruyere A.
        • Rapin C.H.
        Associations between malnutrition, poor general health and oral dryness in hospitalized elderly patients.
        Age Ageing. 1998; 27: 123-128
        • Flink H.
        • Tegelberg A.
        • Sorensen S.
        Hyposalivation and iron stores among individuals with and without active dental caries.
        Acta Odontol Scand. 2000; 58: 265-271
        • Johansson I.
        • Saellström A.-K.
        • Rajan B.P.
        • Parameswaran A.
        Salivary flow and dental caries in Indian children suffering from chronic malnutrition.
        Caries Res. 1992; 26: 38-43
        • Rhodus N.L.
        • Brown J.
        The association of xerostomia and inadequate intake in older adults.
        J Am Diet Assoc. 1990; 90: 1688-1692
        • Mukherji S.
        • Naik S.R.
        • Srivastava P.N.
        • Choudhuri S.N.
        • Chuttani H.K.
        Salivary secretions in iron deficiency anemia.
        Oral Med. 1982; 37: 130-132
        • Bernardi R.
        • Perin C.
        • Becker F.I.
        • Ramos G.Z.
        • Gheno G.Z.
        • Lopez L.R.
        • et al.
        Effect of pilocarpine mouthwash on salivary flow.
        Braz J Med Biol Res. 2002; 35: 105-110
        • Cummins M.J.
        • Papas A.
        • Kammer G.M.
        • Fox P.C.
        Treatment of primary Sjogren’s syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results.
        Arthritis Rheum. 2003; 49: 585-593
        • Fife R.S.
        • Chase W.F.
        • Dore R.K.
        • Wiesenhutter C.W.
        • Lockhart P.B.
        • Tindall E.
        • et al.
        Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome.
        Arch Intern Med. 2002; 162: 1293-1300
        • Khurshudian A.V.
        A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren’s syndrome.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003; 95: 38-44
        • Mariette X.
        • Ravaud P.
        • Steinfeld S.
        • Baron G.
        • Goetz J.
        • Hachulla E.
        • et al.
        Inefficacy of infliximab in primary Sjogren’s syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjogren’s Syndrome (TRIPSS).
        Arthritis Rheum. 2004; 50: 1270-1276
        • Petrone D.
        • Condemi J.J.
        • Fife R.
        • Gluck O.
        • Cohen S.
        • Dalgin P.
        A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren’s syndrome patients with xerostomia and keratoconjunctivits sicca.
        Arthritis Rheum. 2002; 46: 748-754
        • Pillemer S.R.
        • Brennan M.T.
        • Sankar V.
        • Leakan R.A.
        • Smith J.A.
        • Grisius M.
        • et al.
        Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren’s syndrome.
        Arthritis Rheum. 2004; 51: 601-604
        • Rantanen I.
        • Tenovuo J.
        • Pienihäkkinen K.
        • Söderling E.
        Effects of a betaine-containing toothpaste on subjective symptoms of dry mouth: a randomized clinical trial.
        J Contemp Dent Pract. 2003; 4: 11-23
        • Robinson P.G.
        • Pankhurst C.L.
        • Garrett E.J.
        Randomized-controlled trial: effect of a reservoir biteguard on quality of life in xerostomia.
        J Oral Pathol Med. 2005; 34: 193-197
        • Sankar V.
        • Brennan M.T.
        • Kok M.R.
        • Leakan R.A.
        • Smith J.A.
        • Mannay J.
        • et al.
        Etanercept in Sjögren’s syndrome.
        Arthritis Rheum. 2004; 50: 2240-2245
        • Moen K.
        • Kvalvik A.G.
        • Hellem S.
        • Jonsson R.
        • Brun J.G.
        The long-term effect of anti TNF-alpha treatment on temporomandibular joints, oral mucosa, and salivary flow in patients with active rheumatoid arthritis: a pilot study.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 100: 433-440
        • Pijpe J.
        • van Imhoff G.W.
        • Spijkervet F.K.
        • Roodenburg J.L.
        • Wolbink G.J.
        • Mansour K.
        • et al.
        Rituximab treatment in patients with primary Sjogren’s syndrome: an open-label phase II study.
        Arthritis Rheum. 2005; 52: 2740-2750
        • Jedel E.
        Acupuncture in xerostomia—a systematic review.
        J Oral Rehab. 2005; 32: 392-396
        • Fox P.C.
        Salivary enhancement therapies.
        Caries Res. 2004; 38: 241-246
        • Yasuda H.
        • Niki H.
        Review of the pharmacological properties and clinical usefulness of muscarinic agonists for xerostomia in patients with Sjögren’s syndrome.
        Clin Drug. 2002; 22: 67-73
        • Gottenberg J.E.
        • Guillevin L.
        • Lambotte O.
        • Combe B.
        • Allanore Y.
        • Cantagrel A.
        • et al.
        ; Club Rheumatismes et Inflammation (CRI).
        Ann Rheum Dis. 2005; 64: 913-920
        • Steinfeld S.D.
        • Demols P.
        • Appelboom T.
        Infliximab in primary Sjogren’s syndrome: one-year followup.
        Arthritis Rheum. 2002; 46: 3301-3303
        • Zandbelt M.M.
        • de Wilde P.
        • van Damme P.
        • Hoyng C.B.
        • van de Putte L.
        • van den Hoogen F.
        Etanercept in the treatment of patients with primary Sjogren’s syndrome: a pilot study.
        J Rheumatol. 2004; 31: 96-101
        • Ring T.
        • Kallenbach M.
        • Praetorius J.
        • Nielsen S.
        • Melgaard B.
        Successful treatment of a patient with primary Sjogren’s syndrome with rituximab.
        Clin Rheumatol. 2005; 7: 72
        • Somer B.G.
        • Tsai D.E.
        • Downs L.
        • Weinstein B.
        • Schuster S.J.
        American College of Rheumatology ad hoc Committee on Immunologic Testing Guidelines.
        Arthritis Rheum. 2003; 49: 394-398
        • Nusair S.
        • Rubinow A.
        The use of oral pilocarpine in xerostomia and Sjogren’s syndrome.
        Semin Arthritis Rheum. 1999; 28: 360-367
        • Fox P.C.
        • Atkinson J.C.
        • Macynski A.A.
        • Wolff A.
        • Kung D.S.
        • Valdez I.H.
        • et al.
        Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia).
        Arch Intern Med. 1991; 151: 1149-1152
        • Vivino F.B.
        • Al-Hashimi I.
        • Khan Z.
        • LeVegue F.G.
        • Salisbury 3rd, P.L.
        • Tran-Johnson T.K.
        • et al.
        Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized placebo-controlled fixed-dose multicenter trial.
        Arch Intern Med. 1999; 159: 174-181
        • Ship J.A.
        • Fox P.C.
        • Michalek J.E.
        • Cummins M.J.
        • Richards A.B.
        Treatment of primary Sjögren’s syndrome with low-dose natural human interferon-alpha administered by the oral mucosa route: a phase II clinical trial.
        J Interferon Cytokine Res. 1999; 19: 943-951
        • Drosos A.A.
        • van Vliet-Dascalopoulou E.
        • Andonopoulos A.P.
        • Galanopoulou V.
        • Skopouli F.N.
        • Moutsopoulos H.M.
        Nandrolone decanoate (deca-durabolin) in primary Sjogren’s syndrome: a double blind pilot study.
        Clin Exp Rheumatol. 1988; 6: 53-57
      3. US Food and Drug Administration. List of orphan designationed products approved for marketing. Available at: http://www.fda.gov/orphan/designat/Approvals.htm. Accessed May 2005.

        • Blom M.
        • Dawidson I.
        • Angmar-Mansson B.
        The effect of acupuncture on salivary flow rates in patients with xerostomia.
        Oral Surg Oral Med Oral Pathol. 1992; 73: 293-298
        • Blom M.
        • Dawidson I.
        • Fernberg J.O.
        • Johnson G.
        • Angmar-Mansson B.
        Acupuncture treatment of patients with radiation-induced xerostomia.
        Eur J Cancer B Oral Oncol. 1996; 32B: 182-190
        • Christodoulides N.
        • Mohanty S.
        • Miller C.S.
        • Langub M.C.
        • Floriano P.N.
        • Dharshan P.
        • et al.
        Application of microchip assay system for the measurement of C-reactive protein in human saliva.
        Lab Chip. 2005; 5: 261-269
        • Dawson L.J.
        • Fox P.C.
        • Smith P.M.
        Sjögren’s syndrome—the non-apoptotic model of glandular hypofunction.
        Rheumatol. 2006; 45: 792-798
        • Kok M.R.
        • Yamano S.
        • Lodde B.M.
        • Wang J.
        • Couwenhoven R.I.
        • Yakar S.
        • et al.
        Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjogren’s syndrome.
        Hum Gene Ther. 2003; 14: 1605-1618
        • Baum B.J.
        • Zheng C.
        • Cotrim A.P.
        • Goldsmith C.M.
        • Atkinson J.C.
        • Brahim J.S.
        • et al.
        Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction.
        Biochim Biophys Acta. 2006; 1758: 1071-1077
        • Voutetakis A.
        • Kok M.R.
        • Zheng C.
        • Bossis I.
        • Wang J.
        • Cotrim A.P.
        • et al.
        Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics.
        Proc Natl Acad Sci U S A. 2004; 101: 3053-3058